Literature DB >> 27338799

An engineered heterodimeric model to investigate SULT1B1 dependence on intersubunit communication.

Zachary E Tibbs1, Charles N Falany2.   

Abstract

Cytosolic sulfotransferases (SULTs) biotransform small molecules to polar sulfate esters as a means to alter their activities within the body. Understanding the molecular mechanism by which the SULTs perform their function is important for optimizing future therapeutic applications. Recent evidence suggests each SULT isoform acts by a half-site reaction (HSR) mechanism, in which a single SULT dimer subunit is active at any given time. HSR requires communication through the highly conserved KxxxTVxxxE dimerization motif. In this investigation, we sought to test the intersubunit interactions of SULT1B1 as it relates to enzyme activity. We generated two populations of SULT1B1 isoforms that efficiently heterodimerize upon mixing by targeted point mutation of the KxxxTVxxxE motif to KxxxTVxxxK or ExxxTVxxxE. The heterodimer exhibited wildtype-like activity with regard to native size, thermal integrity, PAP affinity, and PAPS Km, therefore serving as a valid model for investigating SULT1B1 dimer subunit interactions. The approach granted control over each independent subunit, permitting mutation of the critical 3'-phosphoadenosine 5'-phosphosulfate (PAPS) binding residue Arg258 and/or the catalytic base His109 in a single subunit of the dimer. Substitution of the dysfunctional subunits for fully active subunits yielded dimeric SULT1B1 with 50% the activity of the fully competent dimer, suggesting SULT1B1 intersubunit communication does not significantly contribute to the isoform's activity. These results are a testament to the unique properties of individual SULT isoforms. The dimerization system described in this manuscript can be used to study subunit interactions in other SULT isoforms as well as proteins in other families.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug metabolism; Half-site reactivity; Protein engineering; SULT1B1; Sulfation

Mesh:

Substances:

Year:  2016        PMID: 27338799      PMCID: PMC4982705          DOI: 10.1016/j.bcp.2016.06.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  27 in total

1.  The dimerization motif of cytosolic sulfotransferases.

Authors:  E V Petrotchenko; L C Pedersen; C H Borchers; K B Tomer; M Negishi
Journal:  FEBS Lett       Date:  2001-02-09       Impact factor: 4.124

Review 2.  Sulfonation and molecular action.

Authors:  Charles A Strott
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

3.  Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1.

Authors:  Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2010-12

4.  Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver.

Authors:  J Wang; J L Falany; C N Falany
Journal:  Mol Pharmacol       Date:  1998-02       Impact factor: 4.436

5.  Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase.

Authors:  L C Pedersen; E V Petrotchenko; M Negishi
Journal:  FEBS Lett       Date:  2000-06-09       Impact factor: 4.124

Review 6.  Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis.

Authors:  Zachary E Tibbs; Katie Jo Rohn-Glowacki; Frank Crittenden; Amber L Guidry; Charles N Falany
Journal:  Drug Metab Pharmacokinet       Date:  2014-11-05       Impact factor: 3.614

7.  Inhibition of M and P phenol sulfotransferase by analogues of 3'-phosphoadenosine-5'-phosphosulfate.

Authors:  S S Rens-Domiano; J A Roth
Journal:  J Neurochem       Date:  1987-05       Impact factor: 5.372

8.  The sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis.

Authors:  Y Kakuta; E V Petrotchenko; L C Pedersen; M Negishi
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

9.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

10.  Structural and chemical profiling of the human cytosolic sulfotransferases.

Authors:  Abdellah Allali-Hassani; Patricia W Pan; Ludmila Dombrovski; Rafael Najmanovich; Wolfram Tempel; Aiping Dong; Peter Loppnau; Fernando Martin; Janet Thornton; Janet Thonton; Aled M Edwards; Alexey Bochkarev; Alexander N Plotnikov; Masoud Vedadi; Cheryl H Arrowsmith
Journal:  PLoS Biol       Date:  2007-05       Impact factor: 8.029

View more
  2 in total

1.  Expression, purification and characterization of human cytosolic sulfotransferase (SULT) 1C4.

Authors:  Amber L Guidry; Zachary E Tibbs; Melissa Runge-Morris; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2017-01-01

2.  Interaction of Native- and Oxidized-Low-Density Lipoprotein with Human Estrogen Sulfotransferase.

Authors:  Akira Sato; Hinako Watanabe; Miyuki Yamazaki; Eiko Sakurai; Keiichi Ebina
Journal:  Protein J       Date:  2021-03-04       Impact factor: 2.371

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.